PBA
Paradigm Biocapital Advisors’s Janux Therapeutics JANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.5M | Sell |
2,920,258
-409,651
| -12% | -$9.46M | 2.88% | 10 |
|
|
2025
Q1 | $89.9M | Sell |
3,329,909
-186,077
| -5% | -$5.02M | 4.12% | 8 |
|
|
2024
Q4 | $188M | Buy |
3,515,986
+1,115,412
| +46% | +$59.7M | 6.55% | 5 |
|
|
2024
Q3 | $109M | Buy |
2,400,574
+836,122
| +53% | +$38M | 3.69% | 7 |
|
|
2024
Q2 | $65.5M | Buy |
+1,564,452
| New | +$65.5M | 2.51% | 15 |
|